MAPT and neurodegenerative disease: To further support the linkage between certain proteins/peptides and neurodegenerative diseases, focusing on AD, we should mention that cerebrospinal fluid (CSF) levels of Aβ- and tau- related biomarkers have been widely employed for confirming AD diagnosis, along with positive amyloid-PET scans [5,19].